The shareholders of Solibro AB will receive 3.9 million shares in Q-Cells in exchange for their stake, with half of the shares subject to a 180-day lock-up period.
Solibro was formed in 2006 by Q-Cells and Solibro AB in order to commercialise copper indium gallium selenide (CIGS) thin-film solar-cell technology that was being developed at Sweden’s University of Uppsala.
Johannes Segner, managing director of Solibro, says thin-film technology is becoming an important aspect of Q-Cells’ strategy for the future.
